Cite Filings / AVIR / 0001373604-24-000114

Feed Companies Filings Check

Sign in

SCHEDULE 13D

Beneficial Ownership Report

Atea Pharmaceuticals, Inc. Filed 2024-12-16 Acc 0001373604-24-000114

Documents 1

SCHEDULE 13D Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-03-04 SCHEDULE 13D Beneficial Ownership Report
2024-12-16 SCHEDULE 13D Beneficial Ownership Report
2024-12-12 4 Director sold 359,606 shares at $2.85 ($1,023,475)
2024-12-10 144 Sale of Securities

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…